​
​

Atara Biotherapeutics (ATRA) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Atara Biotherapeutics Revenue Highlights

Latest Revenue (Y)

$8.57M

Latest Revenue (Q)

$40.19M

Atara Biotherapeutics Revenue by Period

Atara Biotherapeutics Revenue by Year

DateRevenueChange
2023-12-31--86.51%
2022-12-31-212.55%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31--

Atara Biotherapeutics generated $8.57M in revenue during NA 2023, up -86.51% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Atara Biotherapeutics Revenue by Quarter

DateRevenueChange
2024-09-30-40.33%
2024-06-30-4.69%
2024-03-31-543.39%
2023-12-31-98.88%
2023-09-30-123.41%
2023-06-30--21.94%
2023-03-31-454.75%
2022-12-31--95.04%
2022-09-30--91.36%
2022-06-30-605.21%
2022-03-31--3.10%
2021-12-31-40.56%
2021-09-30-38.76%
2021-06-30-8.95%
2021-03-31--99.01%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31--

Atara Biotherapeutics generated $40.19M in revenue during Q3 2024, up 40.33% compared to the previous quarter, and up 4199.58% compared to the same period a year ago.

Atara Biotherapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
APLSApellis Pharmaceuticals--
KPTIKaryopharm Therapeutics--
HRTXHeron Therapeutics--
RCUSArcus Biosciences--
FATEFate Therapeutics--
CRBUCaribou Biosciences--
VECTVectivBio--
TCRXTScan Therapeutics--
HOOKHOOKIPA Pharma--
ITOSiTeos Therapeutics--
MREOMereo BioPharma Group--
ATRAAtara Biotherapeutics--
BTAIBioXcel Therapeutics--
ALLOAllogene Therapeutics--
XFORX4 Pharmaceuticals--
ABOSAcumen Pharmaceuticals--
SANASana Bio--

ATRA Revenue FAQ

What is Atara Biotherapeutics’s yearly revenue?

Atara Biotherapeutics's yearly revenue for 2023 was $8.57M, representing a decrease of -86.51% compared to 2022. The company's yearly revenue for 2022 was $63.57M, representing an increase of 212.55% compared to 2021. ATRA's yearly revenue for 2021 was $20.34M, representing an increase of 100.00% compared to 2020.

What is Atara Biotherapeutics’s quarterly revenue?

Atara Biotherapeutics's quarterly revenue for Q3 2024 was $40.19M, a 40.33% increase from the previous quarter (Q2 2024), and a 1779.79% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $28.64M, a 4.69% increase from the previous quarter (Q1 2024), and a 2892.69% increase year-over-year (Q2 2023). ATRA's quarterly revenue for Q1 2024 was $27.36M, a 543.39% increase from the previous quarter (Q4 2023), and a 2131.40% increase year-over-year (Q1 2023).

What is Atara Biotherapeutics’s revenue growth rate?

Atara Biotherapeutics's revenue growth rate for the last 3 years (2021-2023) was -57.85%, and for the last 5 years (2019-2023) was 0%.